We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A restricted ...

A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), ...

Little is known about the impacts of therapy on adolescent patients with T2DM. In a recent study, adolescents with newly diagnosed T2DM had profound impairment of beta-cell function, but treatment ...

Residual CFTR function in cystic fibrosis was associated with better glucose tolerance and insulin secretion, with CFTR ...

Biomea Fusion, Inc. announced positive results from preclinical experiments showing that its investigational drug icovamenib enhances beta cell function and improves the responsiveness of human islets ...

Biomea Fusion, Inc. has presented promising clinical results for icovamenib, a novel therapy aimed at restoring beta-cell function in patients with type 2 diabetes, at the ATTD 2025 Conference.

New research finds that a low-carbohydrate diet may improve beta-cell function in people with Type 2 diabetes. New research from the University of Alabama at Birmingham, published in the Journal of ...

In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...

Following a low-carb diet may potentially help patients manage disease more effectively and reduce medication use. Study: Effects of a Carbohydrate-Restricted Diet on β-Cell Response in Adults With ...

More than 38 million Americans have diabetes, and more than 90 percent of them have Type 2 diabetes. Type 2 diabetes usually presents in people who are 45 or older. However, it is becoming more common ...